Literature DB >> 18629873

Heparan sulfate proteoglycans: a GAGgle of skeletal-hematopoietic regulators.

Kathryn D Rodgers1, James D San Antonio, Olena Jacenko.   

Abstract

This review summarizes our current understanding of the presence and function of heparan sulfate proteoglycans (HSPGs) in skeletal development and hematopoiesis. Although proteoglycans (PGs) comprise a large and diverse group of cell surface and matrix molecules, we chose to focus on HSPGs owing to their many proposed functions in skeletogenesis and hematopoiesis. Specifically, we discuss how HSPGs play predominant roles in establishing and regulating niches during skeleto-hematopoietic development by participating in distinct developmental processes such as patterning, compartmentalization, growth, differentiation, and maintenance of tissues. Special emphasis is placed on our novel hypothesis that mechanistically links endochondral skeletogenesis to the establishment of the hematopoietic stem cell (HSC) niche in the marrow. HSPGs may contribute to these developmental processes through their unique abilities to establish and mediate morphogen, growth factor, and cytokine gradients; facilitate signaling; provide structural stability to tissues; and act as molecular filters and barriers. Copyright (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18629873      PMCID: PMC2651149          DOI: 10.1002/dvdy.21593

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  254 in total

1.  Recombinant domain IV of perlecan binds to nidogens, laminin-nidogen complex, fibronectin, fibulin-2 and heparin.

Authors:  M Hopf; W Göhring; E Kohfeldt; Y Yamada; R Timpl
Journal:  Eur J Biochem       Date:  1999-02

2.  Differential expression of fibroblast growth factor receptor-1, -2, and -3 and syndecan-1, -2, and -4 in neonatal rat mandibular condyle and calvaria during osteogenic differentiation in vitro.

Authors:  A Molténi; D Modrowski; M Hott; P J Marie
Journal:  Bone       Date:  1999-04       Impact factor: 4.398

3.  Perlecan is essential for cartilage and cephalic development.

Authors:  E Arikawa-Hirasawa; H Watanabe; H Takami; J R Hassell; Y Yamada
Journal:  Nat Genet       Date:  1999-11       Impact factor: 38.330

4.  Fibroblast growth factor receptor signalling is dictated by specific heparan sulphate saccharides.

Authors:  S E Guimond; J E Turnbull
Journal:  Curr Biol       Date:  1999-11-18       Impact factor: 10.834

5.  Expression of glypican-4 in haematopoietic-progenitor and bone-marrow-stromal cells.

Authors:  B Siebertz; G Stöcker; Z Drzeniek; S Handt; U Just; H D Haubeck
Journal:  Biochem J       Date:  1999-12-15       Impact factor: 3.857

6.  VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation.

Authors:  H P Gerber; T H Vu; A M Ryan; J Kowalski; Z Werb; N Ferrara
Journal:  Nat Med       Date:  1999-06       Impact factor: 53.440

7.  Sox9 is required for cartilage formation.

Authors:  W Bi; J M Deng; Z Zhang; R R Behringer; B de Crombrugghe
Journal:  Nat Genet       Date:  1999-05       Impact factor: 38.330

8.  Control of extracellular matrix assembly by syndecan-2 proteoglycan.

Authors:  C M Klass; J R Couchman; A Woods
Journal:  J Cell Sci       Date:  2000-02       Impact factor: 5.285

9.  Expression of the heparan sulfate proteoglycan, perlecan, during mouse embryogenesis and perlecan chondrogenic activity in vitro.

Authors:  M M French; S E Smith; K Akanbi; T Sanford; J Hecht; M C Farach-Carson; D D Carson
Journal:  J Cell Biol       Date:  1999-05-31       Impact factor: 10.539

10.  Perlecan maintains the integrity of cartilage and some basement membranes.

Authors:  M Costell; E Gustafsson; A Aszódi; M Mörgelin; W Bloch; E Hunziker; K Addicks; R Timpl; R Fässler
Journal:  J Cell Biol       Date:  1999-11-29       Impact factor: 10.539

View more
  27 in total

Review 1.  Hematopoietic stem cells: multiparameter regulation.

Authors:  Kedong Song; Liying Li; Yiwei Wang; Tianqing Liu
Journal:  Hum Cell       Date:  2016-02-16       Impact factor: 4.174

2.  Hematopoietic differentiation of induced pluripotent stem cells from patients with mucopolysaccharidosis type I (Hurler syndrome).

Authors:  Jakub Tolar; In-Hyun Park; Lily Xia; Chris J Lees; Brandon Peacock; Beau Webber; Ron T McElmurry; Cindy R Eide; Paul J Orchard; Michael Kyba; Mark J Osborn; Troy C Lund; John E Wagner; George Q Daley; Bruce R Blazar
Journal:  Blood       Date:  2010-10-29       Impact factor: 22.113

3.  Defective endochondral ossification-derived matrix and bone cells alter the lymphopoietic niche in collagen X mouse models.

Authors:  Elizabeth Sweeney; Douglas Roberts; Angela Lin; Robert Guldberg; Olena Jacenko
Journal:  Stem Cells Dev       Date:  2013-06-18       Impact factor: 3.272

4.  Identification of heparin-binding sites in proteins by selective labeling.

Authors:  Alessandro Ori; Paul Free; José Courty; Mark C Wilkinson; David G Fernig
Journal:  Mol Cell Proteomics       Date:  2009-06-30       Impact factor: 5.911

5.  Congenic mice confirm that collagen X is required for proper hematopoietic development.

Authors:  Elizabeth Sweeney; Douglas Roberts; Tina Corbo; Olena Jacenko
Journal:  PLoS One       Date:  2010-03-03       Impact factor: 3.240

6.  Heparan sulfate mimetics can efficiently mobilize long-term hematopoietic stem cells.

Authors:  Fabio Di Giacomo; Daniel Lewandowski; Eric Cabannes; Vanessa Nancy-Portebois; Maurice Petitou; Serge Fichelson; Paul-Henri Romeo
Journal:  Haematologica       Date:  2011-12-16       Impact factor: 9.941

7.  Chondrocyte culture in three dimensional alginate sulfate hydrogels promotes proliferation while maintaining expression of chondrogenic markers.

Authors:  Rami Mhanna; Aditya Kashyap; Gemma Palazzolo; Queralt Vallmajo-Martin; Jana Becher; Stephanie Möller; Matthias Schnabelrauch; Marcy Zenobi-Wong
Journal:  Tissue Eng Part A       Date:  2014-02-06       Impact factor: 3.845

8.  Cartilage tumour progression is characterized by an increased expression of heparan sulphate 6O-sulphation-modifying enzymes.

Authors:  Cathelijn J F Waaijer; Carlos E de Andrea; Andrew Hamilton; Jolieke G van Oosterwijk; Sally E Stringer; Judith V M G Bovée
Journal:  Virchows Arch       Date:  2012-08-18       Impact factor: 4.064

Review 9.  Running GAGs: myxoid matrix in tumor pathology revisited: what's in it for the pathologist?

Authors:  Stefan M Willems; Malgorzata Wiweger; J Frans Graadt van Roggen; Pancras C W Hogendoorn
Journal:  Virchows Arch       Date:  2009-08-25       Impact factor: 4.064

10.  The effect of beta-xylosides on the chondrogenic differentiation of mesenchymal stem cells.

Authors:  Siyuan Li; Anthony J Hayes; Bruce Caterson; Clare E Hughes
Journal:  Histochem Cell Biol       Date:  2012-08-23       Impact factor: 4.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.